Your browser doesn't support javascript.
Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability.
Moon, Suerie; Armstrong, Jana; Hutler, Brian; Upshur, Ross; Katz, Rachel; Atuire, Caesar; Bhan, Anant; Emanuel, Ezekiel; Faden, Ruth; Ghimire, Prakash; Greco, Dirceu; Ho, Calvin Wl; Kochhar, Sonali; Schaefer, G Owen; Shamsi-Gooshki, Ehsan; Singh, Jerome Amir; Smith, Maxwell J; Wolff, Jonathan.
  • Moon S; International Relations and Political Science Department & Interdisciplinary Programmes, Global Health Centre, Graduate Institute of International and Development Studies, Geneva, Switzerland.
  • Armstrong J; Independent Global Health Consultant, Geneva, Switzerland. Electronic address: jana.armstrong@mac.com.
  • Hutler B; Johns Hopkins Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MA, USA.
  • Upshur R; Department of Family and Community Medicine and Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
  • Katz R; Faculty of Health Sciences, Western University, London, ON, Canada.
  • Atuire C; Department of Philosophy and Classics, University of Ghana, Accra, Ghana.
  • Bhan A; Department of Community Medicine and Centre for Ethics, Yenepoya University, Mangalore, India.
  • Emanuel E; Global Initiatives and Healthcare Transformation Institute, University of Pennsylvania, Philadelphia, PA, USA.
  • Faden R; Johns Hopkins Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MA, USA.
  • Ghimire P; Tribhuvan University, Kirtipur, Nepal.
  • Greco D; School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Ho CW; Faculty of Law and Centre for Medical Ethics, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Kochhar S; Department of Global Health, University of Washington, Seattle, WA, USA.
  • Schaefer GO; Centre for Biomedical Ethics, National University of Singapore, Singapore.
  • Shamsi-Gooshki E; Department of Medical Ethics, Tehran University of Medical Sciences, Tehran, Iran.
  • Singh JA; University of KwaZulu-Natal, Durban, South Africa.
  • Smith MJ; Faculty of Health Sciences, Western University, London, ON, Canada.
  • Wolff J; Blavatnik School of Government, University of Oxford, Oxford, UK.
Lancet ; 399(10323): 487-494, 2022 01 29.
Article in English | MEDLINE | ID: covidwho-1671323
ABSTRACT
The Access to COVID-19 Tools Accelerator (ACT-A) is a multistakeholder initiative quickly constructed in the early months of the COVID-19 pandemic to respond to a catastrophic breakdown in global cooperation. ACT-A is now the largest international effort to achieve equitable access to COVID-19 health technologies, and its governance is a matter of broad public importance. We traced the evolution of ACT-A's governance through publicly available documents and analysed it against three principles embedded in the founding mission statement of ACT-A participation, transparency, and accountability. We found three challenges to realising these principles. First, the roles of the various organisations in ACT-A decision making are unclear, obscuring who might be accountable to whom and for what. Second, the absence of a clearly defined decision making body; ACT-A instead has multiple centres of legally binding decision making and uneven arrangements for information transparency, inhibiting meaningful participation. Third, the nearly indiscernible role of governments in ACT-A, raising key questions about political legitimacy and channels for public accountability. With global public health and billions in public funding at stake, short-term improvements to governance arrangements can and should now be made. Efforts to strengthen pandemic preparedness for the future require attention to ethical, legitimate arrangements for governance.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Global Health / Clinical Governance / Pandemics / COVID-19 / International Cooperation Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: Lancet Year: 2022 Document Type: Article Affiliation country: S0140-6736(21)02344-8

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Global Health / Clinical Governance / Pandemics / COVID-19 / International Cooperation Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: Lancet Year: 2022 Document Type: Article Affiliation country: S0140-6736(21)02344-8